000950 重药控股
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(3,150,268)508,534285,829250,165631,986
投资活动产生之现金流量净额(183,398)(358,384)(191,239)(969,508)(1,957,119)
筹资活动产生之现金流量净额1,059,069252,4921,179,8701,542,2031,626,974
汇率变动对现金及现金等价物的影响------(120)(9)
现金及现金等价物净增加/(减少)(2,274,597)402,6421,274,459822,740301,832
期初现金及现金等价物余额5,107,8504,705,2073,430,7482,608,0082,306,176
期末现金及现金等价物余额2,833,2535,107,8504,705,2073,430,7482,608,008